Mechanism of action of anti-hypercholesterolemia drugs and their resistance
- PMID: 25151024
- DOI: 10.1016/j.ejphar.2014.07.048
Mechanism of action of anti-hypercholesterolemia drugs and their resistance
Abstract
Coronary artery disease is one of the leading causes of death worldwide. One of the significant causes of this disease is hypercholesterolemia which is the result of various genetic alterations that are associated with the accumulation of specific classes of lipoprotein particles in plasma. A number of drugs are used to treat hypercholesterolemia like statin, fibrate, bile acid sequestrants, niacin, ezetimibe, omega-3 fatty acids and natural extracts. It has been observed that these drugs show diverse response in different individuals. The present review explains the mechanism of action of these drugs as well as mechanism of its lesser effectiveness or resistance in some individuals. There are various identified genetic variations that are associated with diversity in the drugs response. Therefore, present study helps to understand the ethiology of drug mechanism and resistance developed against drugs used to treat hypercholesterolemia.
Keywords: Anti-hypercholesterolemia drugs; Fibrate resistance; Hypercholesterolemia; Statin resistance.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Resistance and intolerance to statins.Nutr Metab Cardiovasc Dis. 2014 Oct;24(10):1057-66. doi: 10.1016/j.numecd.2014.05.009. Epub 2014 Jun 6. Nutr Metab Cardiovasc Dis. 2014. PMID: 24996502 Review.
-
Structural mechanism for statin inhibition of HMG-CoA reductase.Science. 2001 May 11;292(5519):1160-4. doi: 10.1126/science.1059344. Science. 2001. PMID: 11349148
-
Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.J Womens Health (Larchmt). 2004 Dec;13(10):1101-7. doi: 10.1089/jwh.2004.13.1101. J Womens Health (Larchmt). 2004. PMID: 15650343
-
Pitavastatin.Int J Clin Pract. 2005 Feb;59(2):239-52. doi: 10.1111/j.1742-1241.2005.00461.x. Int J Clin Pract. 2005. PMID: 15854203 Review.
-
Molecular pathways and agents for lowering LDL-cholesterol in addition to statins.Pharmacol Ther. 2010 Jun;126(3):263-78. doi: 10.1016/j.pharmthera.2010.02.006. Epub 2010 Mar 19. Pharmacol Ther. 2010. PMID: 20227438 Review.
Cited by
-
Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?Int J Mol Sci. 2022 Aug 18;23(16):9326. doi: 10.3390/ijms23169326. Int J Mol Sci. 2022. PMID: 36012589 Free PMC article. Review.
-
Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway.Front Pharmacol. 2022 Apr 28;13:857092. doi: 10.3389/fphar.2022.857092. eCollection 2022. Front Pharmacol. 2022. PMID: 35571088 Free PMC article.
-
AGR2-induced cholesterol synthesis drives lovastatin resistance that is overcome by combination therapy with allicin.Acta Pharmacol Sin. 2022 Nov;43(11):2905-2916. doi: 10.1038/s41401-022-00909-3. Epub 2022 Apr 22. Acta Pharmacol Sin. 2022. PMID: 35459869 Free PMC article.
-
A Modern Approach to Dyslipidemia.Endocr Rev. 2022 Jul 13;43(4):611-653. doi: 10.1210/endrev/bnab037. Endocr Rev. 2022. PMID: 34676866 Free PMC article.
-
Daily Consumption of Caper Fruit Along With Atorvastatin Has Synergistic Effects in Hyperlipidemic Patients: Randomized Clinical Trial.Galen Med J. 2019 May 27;8:e1345. doi: 10.31661/gmj.v0i0.1345. eCollection 2019. Galen Med J. 2019. PMID: 34466497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
